These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 880264)

  • 41. Inhibition of dopamine-beta-hydroxylase by spinochrome A and echinochrome A, naphthoquinone pigments of echinoids.
    Kuzuya H; Ikuta K; Nagatsu T
    Biochem Pharmacol; 1973 Nov; 22(21):2722-4. PubMed ID: 4763606
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of ATP upon dopamine-beta-hydroxylase.
    Laduron PM
    Biochem Pharmacol; 1975 Aug; 24(16):1547-9. PubMed ID: 1191313
    [No Abstract]   [Full Text] [Related]  

  • 43. Selective inhibition of dopamine-beta-hydroxylase in the peripheral tissues by 5-dimethyldithiocarbamylpicolinic acid; its effect on stress-induced ulcer, ethanol-induced sleep and blood pressure.
    Hidaka H; Hara F; Harada N; Hashizume Y; Yano M
    J Pharmacol Exp Ther; 1974 Dec; 191(3):384-92. PubMed ID: 4473535
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of unithiol (2-mercapto-propane-sulfonate sodium) on amphetamine stimulated motor activity, evipan anesthesia and dopamine beta hydroxylase activity].
    Stoĭchev T; Koleva M; Kirova A
    Eksp Med Morfol; 1974; 13(2):118-23. PubMed ID: 4465084
    [No Abstract]   [Full Text] [Related]  

  • 45. Occurrence and some properties of a protein-like inhibitor of dopamine beta-hydroxylase in rat liver.
    Oyama H; Izumi H; Ozawa H; Tuboi S
    Biochem Pharmacol; 1977 Nov; 26(21):1985-90. PubMed ID: 336050
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.
    Melander A; Hallengren B; Rosendal-Helgesen S; Sjöberg AK; Wählin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):295-9. PubMed ID: 6156842
    [No Abstract]   [Full Text] [Related]  

  • 47. Anti-thyroid drugs and lymphocyte function. II. The in vivo effect on blastogenesis and suppressor cell activity in Graves' disease.
    Goldrath N; Shoham J; Bank H; Eisenstein Z
    Clin Exp Immunol; 1982 Oct; 50(1):62-9. PubMed ID: 6217001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of thionamides on adenyl cyclase activity and phospholipogenesis in rat thyroids.
    Pahuja DN; Ganatra RD; Shah DH
    Biochem Pharmacol; 1978 Feb; 27(4):487-9. PubMed ID: 629808
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthesis of substituted DL-3(5-benzazolyl)alanines as dopa and alpha-methyldopa analogs and their effects on dopamine beta-hydroxylase, tyrosinase and diphenoloxidase.
    Loriga M; Paglietti G; Sparatore F; Pinna G; Sisini A
    Farmaco; 1992 Apr; 47(4):439-48. PubMed ID: 1388592
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Degradation of thyroid hormones by phagocytosing human leukocytes.
    Klebanoff SJ; Green WL
    J Clin Invest; 1973 Jan; 52(1):60-72. PubMed ID: 4629909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of propylthiouracil and methimazole pre-treatment on the outcome of iodine-131 therapy in hyperthyroid patients with Graves' disease.
    Shi GM; Xu Q; Zhu CY; Yang YL
    J Int Med Res; 2009; 37(2):576-82. PubMed ID: 19383254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methimazole and propylthiouracil inhibit the oxygen free radical-induced expression of a 72 kilodalton heat shock protein in Graves' retroocular fibroblasts.
    Heufelder AE; Wenzel BE; Bahn RS
    J Clin Endocrinol Metab; 1992 Apr; 74(4):737-42. PubMed ID: 1532179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme.
    Orcutt JC; Molinoff PB
    J Pharmacol Exp Ther; 1977 Sep; 202(3):590-600. PubMed ID: 894523
    [No Abstract]   [Full Text] [Related]  

  • 54. Indirect and direct inhibition of dopamine beta-hydroxylase by amphetamine in storage vesicles and synaptosomes.
    Lau C; Slotkin TA
    Br J Pharmacol; 1976 Jun; 57(2):223-8. PubMed ID: 779909
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effects of antithyroid drugs on intercellular mediators.
    Wilson R; McKillop JH; Travers M; Smith J; Smith E; Thomson JA
    Acta Endocrinol (Copenh); 1990 May; 122(5):605-9. PubMed ID: 2112814
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thyroid peroxidase-catalyzed delabeling of 131 I-diiodotyrosine and 131 I-thyroxine.
    Van Zyl A; Dorris ML; Taurog A
    Endocrinology; 1974 Oct; 95(4):1166-73. PubMed ID: 4416646
    [No Abstract]   [Full Text] [Related]  

  • 57. Reversal of alcohol-induced inhibition of plasma protein synthesis by propylthiouracil.
    Nadkarni GD; Deshpande UR; Pahuja DN
    Biochem Med; 1979 Aug; 22(1):64-9. PubMed ID: 496932
    [No Abstract]   [Full Text] [Related]  

  • 58. Effects of propylthiouracil and methylmercaptoimidazol on metabolism of thyroid hormones by cultured monkey hepatocarcinoma cells.
    Sorimachi K; Robbins J
    Horm Metab Res; 1979 Jan; 11(1):39-43. PubMed ID: 107104
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
    Engler H; Taurog A; Dorris ML
    Endocrinology; 1982 Jan; 110(1):190-7. PubMed ID: 7053983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Studies of HLA-DR expression on cultured human thyrocytes: effect of antithyroid drugs and other agents on interferon-gamma-induced HLA-DR expression.
    Aguayo J; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1988 May; 66(5):903-8. PubMed ID: 3129449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.